26Mar 2023
Trajectory of glycated haemoglobin over time, using real‐world data, in type 2 diabetes patients with obesity on a U‐100 basal‐bolus insulin regimen

Trajectory of glycated haemoglobin over time, using real‐world data, in type 2 diabetes patients with obesity on a U‐100 basal‐bolus insulin regimen

The study aimed to identify patient clusters with poor glucose control among type 2 diabetes mellitus patients with obesity receiving basal-bolus insulin and to identify potential therapeutic inertia factors associated with poor control. Using glycated haemoglobin trajectories over 3 years, six distinct HbA1c trajectories were identified through an unsupervised clustering procedure. Black ethnicity, not initiating noninsulin antihyperglycaemic agents, low adherence, and reduced insulin prescription refills were factors associated with poorer HbA1c clusters and persistent HbA1c missingness. The study highlights the potential for therapeutic inertia among T2DM patients with obesity on basal-bolus insulin, and subgrouping patients based on HbA1c missingness and trajectories can inform disease management strategies.

  • #endo-diabetology

Like

Save

Share